HCA Healthcare

HCA · NYSE · USD

$426.69Change from previous close: +0.78%Absolute change: +$3.30

Close · October 2, 2026

At a glance

Revenue growth
+7.08%
2025 vs 2024
Net income growth
+17.78%
2025 vs 2024
Net margin
9.0%
2024: 8.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total revenue20,23019,10919,51319,16118,605—
Cost of revenue11,17611,13611,33711,14610,982—
Gross profit9,0547,9738,1768,0157,623—
Selling, general and administrative—————7,997
Operating income3,0672,8633,1782,9652,967—
EBIT3,0932,8713,2442,9792,983—
EBITDA4,0373,8014,1553,8683,846—
Interest expense599584572561568—
Pre-tax income2,4942,2872,6722,4182,415—
Income tax564430509515524—
Net income1,6991,6201,8781,6431,653—
Net income to common shareholders1,6991,6201,8781,6431,653—
Basic EPS7.797.288.367.157.00—
Diluted EPS7.627.158.146.966.83—
Average shares (basic)218223225230236—
Average shares (diluted)223227231236242—